Patents by Inventor Dayton Gray Thorpe

Dayton Gray Thorpe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD TO DETERMINE INDIVIDUALIZED INSULIN SENSITIVITY AND OPTIMAL INSULIN DOSE BY LINEAR REGRESSION, AND RELATED SYSTEMS
    Publication number: 20200015760
    Abstract: This invention relates to a method and a device for predicting the glucose concentration of a subject and recommending therapeutic action. The responses of the user's glucose to administered doses of insulin, dietary carbohydrates, and other factors influencing glucose concentration are measured individually for a given user. Once these responses are learned as a function of time, the method and device can receive information about the factors that have been recently or will soon be administered and can recommend which other factors should also be administered.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 16, 2020
    Inventors: Dayton Gray Thorpe, Jonathan S. Landy
  • Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
    Patent number: 10456090
    Abstract: This invention relates to a method and a device for predicting the glucose concentration of a subject and recommending therapeutic action. The responses of the user's glucose to administered doses of insulin, dietary carbohydrates, and other factors influencing glucose concentration are measured individually for a given user. Once these responses are learned as a function of time, the method and device can receive information about the factors which that have been recently or will soon be administered and can recommend which other factors should also be administered.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: October 29, 2019
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Dayton Gray Thorpe, Jonathan S. Landy
  • Method to Determine Individualized Insulin Sensitivity and Optimal Insulin Dose by Linear Regression
    Publication number: 20160162797
    Abstract: This invention relates to a method and a device for predicting the glucose concentration of a subject and recommending therapeutic action. The responses of the user's glucose to administered doses of insulin, dietary carbohydrates, and other factors influencing glucose concentration are measured individually for a given user. Once these responses are learned as a function of time, the method and device can receive information about the factors which have been recently or will soon be administered and can recommend which other factors should also be administered.
    Type: Application
    Filed: November 20, 2015
    Publication date: June 9, 2016
    Inventors: Dayton Gray Thorpe, Jonathan S. Landy